https://www.selleckchem.com/products/nst-628.html
Patients on dialysis are at high risk of complications related to implantable cardioverter defibrillator (ICD) implantation; use of subcutaneous ICDs may be preferred over transvenous devices due to lower risk of bloodstream infection and interference with vascular access sites. We evaluated trends in use and in-hospital outcomes of subcutaneous compared with transvenous ICDs among patients on dialysis in the United States. Retrospective analysis of ICD implants from 2012 to 2018 among patients on dialysis reported to the National Cardi
Like
Comment
Share
